Technical Analysis for MEDXF - Medexus Pharmaceuticals Inc

Grade Last Price % Change Price Change
F 5.45 -2.09% -0.1161
MEDXF closed down 2.09 percent on Friday, March 5, 2021, on 1.73 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical MEDXF trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -2.09%
Oversold Stochastic Weakness -2.09%
50 DMA Resistance Bearish -5.71%
NR7 Range Contraction -5.71%
Inside Day Range Contraction -5.71%
Wide Bands Range Expansion -5.71%
Oversold Stochastic Weakness -5.71%
50 DMA Resistance Bearish -4.02%
Older End-of-Day Signals for MEDXF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc Description

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.


Classification

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Keywords: Medical Specialties Clinical Medicine Pharmaceutical Immunology Arthritis Allergy Rheumatoid Arthritis Recombinant Transplantation Allergic Rhinitis Allergology Brain Tumor Rhinitis Trex Hemophilia Brain Tumors Dexus Immunosuppressants Medex Seasonal Allergic Rhinitis

Is MEDXF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.76
52 Week Low 2.01
Average Volume 26,733
200-Day Moving Average 0.0000
50-Day Moving Average 5.9726
20-Day Moving Average 6.3972
10-Day Moving Average 5.8042
Average True Range 0.4555
ADX 25.3
+DI 16.9377
-DI 28.7103
Chandelier Exit (Long, 3 ATRs ) 6.3935
Chandelier Exit (Short, 3 ATRs ) 6.5865
Upper Bollinger Band 7.7274
Lower Bollinger Band 5.0670
Percent B (%b) 0.14
BandWidth 41.5869
MACD Line -0.1553
MACD Signal Line 0.0069
MACD Histogram -0.1622
Fundamentals Value
Market Cap 78.77 Million
Num Shares 14.5 Million
EPS
Price-to-Sales 0.85
Price-to-Book 3.23
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.1700
Resistance 3 (R3) 6.1733 5.9367 6.0500
Resistance 2 (R2) 5.9367 5.7533 5.9350 6.0100
Resistance 1 (R1) 5.6933 5.6400 5.5750 5.6900 5.9700
Pivot Point 5.4567 5.4567 5.3975 5.4550 5.4567
Support 1 (S1) 5.2133 5.2733 5.0950 5.2100 4.9300
Support 2 (S2) 4.9767 5.1600 4.9750 4.8900
Support 3 (S3) 4.7333 4.9767 4.8500
Support 4 (S4) 4.7300